Organogenesis gets FDA approval to file BLA for knee osteoarthritis treatment

April 6, 2026 5:30 PM

Organogenesis Holdings Inc. (NASDAQ: ORGO) announced it completed a Type-B meeting with the Food and Drug Administration that confirmed the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found